Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

849217-68-1Cabozantinib Reference Standard

● Under Development

Catalogue No.:	VE0028086
CAS No.:	849217-68-1
Mol. Formula:	C28H24FN3O5
Mol. Weight:	501.51 g/mol

How can we help?

Add to RFQ list

Additional information on CAS 849217-68-1

Parent drug

Cabozantinib

IUPAC Name

N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

O=C(NC1=CC=C(OC2=C(C=C(OC)C(OC)=C3)C3=NC=C2)C=C1)C4(C(NC5=CC=C(C=C5)F)=O)CC4

InChI

InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)

Description

Cabozantinib Reference Standard (CAS 849217-68-1) is a high-purity, fully characterized analytical standard supplied for precise method development and assay calibration. Each lot is accompanied by a Certificate of Analysis documenting identity and purity determined by validated HPLC, structural confirmation by NMR and mass spectrometry, and ancillary data such as melting point and water content. The material is provided as a stable solid in amber glass packaging with batch traceability and recommended storage conditions noted on the certificate. Comprehensive stability and analytical data support reproducible performance and regulatory-grade documentation for laboratory quality assurance.